Crescent Biopharma, Inc. (CBIO) Revenue by Year
Crescent Biopharma, Inc. generated $10.8M in revenue in fiscal year 2025. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Crescent Biopharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CBIO Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
CBIO Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Crescent Biopharma, Inc. financials
Frequently Asked Questions
What was Crescent Biopharma, Inc.'s revenue in fiscal year 2025?
Crescent Biopharma, Inc. generated $10.8M in revenue in fiscal year 2025.
How has Crescent Biopharma, Inc.'s revenue changed over the years?
Across the 14 fiscal years this page covers, Crescent Biopharma, Inc. (CBIO) revenue went from $15.3M in fiscal year 2012 to $10.8M in fiscal year 2025.
What was Crescent Biopharma, Inc.'s revenue in the most recent quarter?
Crescent Biopharma, Inc. (CBIO) reported $0 in revenue in Q2 2026.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Crescent Biopharma, Inc. (CBIO) reported on that line in every period on record.